Compare · GDRX vs INFY
GDRX vs INFY
Side-by-side comparison of GoodRx Holdings Inc. (GDRX) and Infosys Limited (INFY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GDRX and INFY operate in EDP Services (Technology), so they compete in similar markets.
- INFY is the larger of the two at $46.61B, about 43.8x GDRX ($1.06B).
- Over the past year, GDRX is down 34.2% and INFY is down 36.9% - GDRX leads by 2.7 points.
- GDRX has been more active in the news (4 items in the past 4 weeks vs 1 for INFY).
- Both have 25 recent analyst ratings on file.
- Company
- GoodRx Holdings Inc.
- Infosys Limited
- Price
- -
- -
- Market cap
- $1.06B
- $46.61B
- 1M return
- +14.44%
- -4.17%
- 1Y return
- -34.24%
- -36.91%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 4
- 1
- Recent ratings
- 25
- 25
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Infosys Limited
Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish - an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.
Latest GDRX
- Officer Mcginnis Christopher A converted options into 36,988 shares and covered exercise/tax liability with 16,294 shares, increasing direct ownership by 12% to 198,310 units (SEC Form 4)
- Officer Barnes Wendy Lynn covered exercise/tax liability with 120,456 shares and converted options into 277,288 shares, increasing direct ownership by 27% to 741,657 units (SEC Form 4)
- Chief Accounting Officer Chan Thomas (Tc) converted options into 5,792 shares and covered exercise/tax liability with 2,947 shares, increasing direct ownership by 50% to 8,580 units (SEC Form 4)
- GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call
- GoodRx Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Rey-Giraud Agnes was granted 73,434 shares, increasing direct ownership by 21% to 426,286 units (SEC Form 4)
- Director Kennedy Kelly J. was granted 73,434 shares, increasing direct ownership by 55% to 207,645 units (SEC Form 4)
- Director Hirsch Douglas Joseph was granted 73,434 shares, increasing direct ownership by 30% to 320,936 units (SEC Form 4)
- Director Bruehlman Ronald E was granted 73,434 shares, increasing direct ownership by 55% to 207,352 units (SEC Form 4)
- Director Bezdek Trevor was granted 73,434 shares, increasing direct ownership by 27% to 343,810 units (SEC Form 4)
Latest INFY
- SEC Form 6-K filed by Infosys Limited
- Wells Fargo initiated coverage on Infosys with a new price target
- SEC Form 6-K filed by Infosys Limited
- SEC Form 6-K filed by Infosys Limited
- Infosys Collaborates with Sentara to Unlock AI Value and Scale Enterprise AI Adoption in Healthcare Services
- Infosys, ANA's Global CMO Growth Council, and LIONS Unveil the CMO AI Hub
- Infosys Announces Expanded Collaboration with GlobalFoundries to Accelerate AI-Driven Transformation of IT Operations
- Infosys Collaborates with Valmet to Reimagine IT Operations with AI Accelerated Transformation
- SEC Form 20-F filed by Infosys Limited
- Infosys Collaborates with CMMI Institute to Shape Enterprise AI Maturity Framework; Achieves Milestone Recognition